Novavax’s Covid-19 vaccine gets US nod as latest pandemic weapon

As the FDA approves the first Covid-19 vaccine of this kind, EU officials continue to evaluate Novavax’s shot as a booster for adults.

Photo: Dado Ruvic/Reuters/Ritzau Scanpix

Novavax Inc.’s Covid-19 vaccine was cleared by US regulators, giving Americans another tool against the virus as cases start to rise again.

The US Food and Drug Administration’s (FDA) nod makes Novavax’s the first vaccine authorized for adults that mimics the protein that the coronavirus uses to enter cells.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs